<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE rdf:RDF [
	<!ENTITY bfo "http://purl.obolibrary.org/obo/">
	<!ENTITY bmic-material "https://spec.industrialontologies.org/ontology/biopharma/Material/">
	<!ENTITY dc "http://purl.org/dc/elements/1.1/">
	<!ENTITY dcterms "http://purl.org/dc/terms/">
	<!ENTITY dtype "http://www.linkedmodel.org/schema/dtype#">
	<!ENTITY iof-av "https://spec.industrialontologies.org/ontology/core/meta/AnnotationVocabulary/">
	<!ENTITY iof-construct "https://spec.industrialontologies.org/ontology/construct/">
	<!ENTITY iof-core "https://spec.industrialontologies.org/ontology/core/Core/">
	<!ENTITY owl "http://www.w3.org/2002/07/owl#">
	<!ENTITY qudt "http://qudt.org/schema/qudt/">
	<!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#">
	<!ENTITY skos "http://www.w3.org/2004/02/skos/core#">
	<!ENTITY vaem "http://www.linkedmodel.org/schema/vaem#">
	<!ENTITY xsd "http://www.w3.org/2001/XMLSchema#">
]>
<rdf:RDF xml:base="https://spec.industrialontologies.org/ontology/biopharma/Material/"
	xmlns:bfo="http://purl.obolibrary.org/obo/"
	xmlns:bmic-material="https://spec.industrialontologies.org/ontology/biopharma/Material/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:dcterms="http://purl.org/dc/terms/"
	xmlns:dtype="http://www.linkedmodel.org/schema/dtype#"
	xmlns:iof-av="https://spec.industrialontologies.org/ontology/core/meta/AnnotationVocabulary/"
	xmlns:iof-construct="https://spec.industrialontologies.org/ontology/construct/"
	xmlns:iof-core="https://spec.industrialontologies.org/ontology/core/Core/"
	xmlns:owl="http://www.w3.org/2002/07/owl#"
	xmlns:qudt="http://qudt.org/schema/qudt/"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
	xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
	xmlns:skos="http://www.w3.org/2004/02/skos/core#"
	xmlns:vaem="http://www.linkedmodel.org/schema/vaem#"
	xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
	
	<owl:Ontology rdf:about="https://spec.industrialontologies.org/ontology/biopharma/Material/">
		<rdfs:label xml:lang="en-US">Material Ontology</rdfs:label>
		<dcterms:abstract>This module contains terms and relations enabling representation of material types and their associated properties. Terms for characterizing material usages in internal operation systems are also included (e.g., consumable, process intermediate, final product…).</dcterms:abstract>
		<dcterms:contributor>Adlane Rebai, Millipore Sigma</dcterms:contributor>
		<dcterms:contributor>Ana Nikolov, OAGi</dcterms:contributor>
		<dcterms:contributor>Boonserm Kulvatunyou, NIST</dcterms:contributor>
		<dcterms:contributor>Cameron Gibbs, CrownPoint Technologies, LLC</dcterms:contributor>
		<dcterms:contributor>Gabriela Henning, NIST</dcterms:contributor>
		<dcterms:contributor>Jan Kemper, AstraZeneca</dcterms:contributor>
		<dcterms:contributor>Marie-Aude Coutouly, Millipore Sigma</dcterms:contributor>
		<dcterms:contributor>Melissa Weller, CrownPoint Technologies, LLC</dcterms:contributor>
		<dcterms:contributor>Milos Drobnjakovic, OAGi</dcterms:contributor>
		<dcterms:contributor>Stephen J. Granite, CrownPoint Technologies, LLC</dcterms:contributor>
		<dcterms:contributor>Stephen Kahmann, CrownPoint Technologies, LLC</dcterms:contributor>
		<dcterms:creator>NIIMBL BD-1 Ontology Group</dcterms:creator>
		<dcterms:license rdf:datatype="&xsd;anyURI">http://opensource.org/licenses/MIT</dcterms:license>
		<dcterms:title>NIIMBL Material Ontology</dcterms:title>
		<owl:imports rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/ReferenceOntologyCandidates/"/>
		<owl:imports rdf:resource="https://spec.industrialontologies.org/ontology/core/Core/"/>
		<owl:versionIRI rdf:resource="https://spec.industrialontologies.org/ontology/202501/biopharma/Material/"/>
		<iof-av:copyright>Copyright (c) 2024, 2025, Open Applications Group</iof-av:copyright>
		<iof-av:maturity rdf:resource="&iof-av;Released"/>
	</owl:Ontology>
	
	<owl:Class rdf:about="&iof-construct;BufferSolution">
		<rdfs:subClassOf rdf:resource="&iof-construct;Solution"/>
		<rdfs:subClassOf>
			<owl:Restriction>
				<owl:onProperty rdf:resource="&iof-core;hasFunction"/>
				<owl:someValuesFrom rdf:resource="&iof-construct;BufferingCapacity"/>
			</owl:Restriction>
		</rdfs:subClassOf>
		<rdfs:label>buffer solution</rdfs:label>
		<iof-av:adaptedFrom>http://purl.obolibrary.org/obo/NCIT_C70815 and https://www.fda.gov/files/drugs/published/pH-Adjuster-Webinar-Slides.pdf</iof-av:adaptedFrom>
		<iof-av:naturalLanguageDefinition>solution consisting of a mixture of a weak acid and its conjugate base or a weak base and its conjugate acid which is resistant to pH changes upon addition of an acidic or basic component</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;BufferingCapacity">
		<rdfs:subClassOf rdf:resource="&iof-core;Capability"/>
		<rdfs:label>buffering capacity</rdfs:label>
		<iof-av:explanatoryNote>Buffering capacity is influenced by the concentration of the buffering species, the proximity of their pKₐ values, and the relationship between solution pH and pKₐ. In mixtures of weak acids and bases, buffering capacities are additive, and higher overall concentrations confer greater resistance to pH changes. Buffer effectiveness is maximal when the pH of the solution equals the pKₐ of the buffering species, where the acid and its conjugate base are present in equal proportion. Effective buffering is generally maintained within ±1 pH unit of the pKₐ; beyond this range, the capacity to resist pH change diminishes significantly.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>capability of a solution to resist changes in hydrogen ion concentration (pH) when an acid or base is added.</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;Cell">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000030"/>
		<rdfs:label xml:lang="en-US">cell</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:example>CHO-K1 cell; HeLa cell; T cell isolated from peripheral blood;Freshly isolated hepatocyte; Hematopoietic stem cell isolated from bone marrow</skos:example>
		<iof-av:directSource>http://purl.obolibrary.org/obo/CL_0000000</iof-av:directSource>
		<iof-av:explanatoryNote>1) From CL term: The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).
2) In the cell line ontology the term is directly under material entity. However, given the definitional criteria of a plasma membrane and maximal connectedness of cell compartments, the cell has been put under object within the ontology.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>Cell(x) → Object(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">object of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are currently insufficient constructs to represent cellular components or cell derivation</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;cell&apos; then x is an &apos;object&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CellBank">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000027"/>
		<rdfs:label>cell bank</rdfs:label>
		<iof-av:naturalLanguageDefinition>object aggregate that has as parts cryopreserved cell aliquots derived from a single source culture, prepared and stored under defined conditions, and maintained as a referenceable lot to provide consistent starting material for research, development, manufacturing, or the generation of new cell banks</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CellCulture">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:subClassOf>
			<owl:Restriction>
				<owl:onProperty rdf:resource="&bfo;BFO_0000110"/>
				<owl:someValuesFrom rdf:resource="&iof-construct;CultureMedium"/>
			</owl:Restriction>
		</rdfs:subClassOf>
		<rdfs:subClassOf>
			<owl:Restriction>
				<owl:onProperty rdf:resource="&bfo;BFO_0000110"/>
				<owl:someValuesFrom rdf:resource="&iof-construct;CulturedCellPopulation"/>
			</owl:Restriction>
		</rdfs:subClassOf>
		<rdfs:label xml:lang="en-US">cell culture</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:altLabel xml:lang="en-US">culture broth</skos:altLabel>
		<skos:example>CHO Suspension Culture in CD-CHO Medium; HEK293 Monolayer in DMEM + 10% FBS;</skos:example>
		<iof-av:adaptedFrom>OBI:0001876</iof-av:adaptedFrom>
		<iof-av:counterExample>In situ cells are observed and studied within their natural tissue context without being cultured or removed, e.g., neurons, alveolar epithelial cells; Post-centrifugation cell pellet; Uninoculated Culture Medium; Glass Slide with Fixed Cells (No Live Media); Tissue Biopsy in PBS Buffer</iof-av:counterExample>
		<iof-av:explanatoryNote>A cell culture includes the cells in culture, as well as the media and all additives in which the cells are being grown or in which they are stored.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>CellCulture(x) → MaterialEntity(x) ∧ ∃y (CultureMedium(y) ∧ hasContinuantPartAtAllTimes(x, y)) ∧ ∃z (CulturedCellPopulation(z) ∧ hasContinuantPartAtAllTimes(x, z))</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">material entity that has cultured cells and the media in which they are being propagated or stored as parts</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There is currently a lack of a constituency relation (is made of) in this release. It is expected that that relation will be available in the next release of IOF Core</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;cell culture&apos; then x is a &apos;material entity&apos; and x &apos;has continuant part at all times&apos; some &apos;culture medium&apos; and x &apos;has continuant part at all times&apos;  some &apos;cultured cell population&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CellLine">
		<rdfs:subClassOf rdf:resource="&iof-construct;CulturedCellPopulation"/>
		<rdfs:label xml:lang="en-US">cell line</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:example>HeLa cells; HEK293 cells; Vero cells</skos:example>
		<iof-av:adaptedFrom>CLO:0000031 and https://www.fda.gov/media/78428/download</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>1) A cell line is typically stored in a cell bank and used to ensure consistent and reproducible performance across experimental or manufacturing contexts.
2) The term excludes freshly isolated or short-lived primary cultures.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>CellLine(x) → CulturedCellPopulation(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">cultured cell population that is derived from a primary cell source and that has been propagated through repeated subculture under defined conditions, resulting in a genetically stable and homogeneous population of cells with a shared propagation history</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are insufficient constructs to define necessary and sufficient conditions.</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;cell line&apos; then x is a &apos;cultured cell population&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CellLineLineage">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000182"/>
		<rdfs:label xml:lang="en-US">cell line lineage</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&bfo;BFO_0000182">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&bfo;BFO_0000184"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;CellLine"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<skos:altLabel>cell line history</skos:altLabel>
		<skos:example>HEK293 history: derived from human embryonic kidney cells transfected with adenovirus 5 DNA; selected for stable growth in culture;</skos:example>
		<iof-av:adaptedFrom>CLO:0000171</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>The cell line lineage may include the original cell type from a tissue and organism that derives the cell line cell. It may also include the cell line passage and cell culturing information.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicDefinition>CellLineLineage(x) ↔ History(x) ∧ ∃y(CellLine(y) ∧ historyOf(x, y))</iof-av:firstOrderLogicDefinition>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">history of the development of a cell line</iof-av:naturalLanguageDefinition>
		<iof-av:semiFormalNaturalLanguageDefinition>every instance of &apos;cell line lineage&apos; is defined as exactly an instance of &apos;history&apos; that &apos;is history of&apos; some &apos;cell line&apos;</iof-av:semiFormalNaturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CellPopulation">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000027"/>
		<rdfs:label xml:lang="en-US">cell population</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&bfo;BFO_0000027">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&bfo;BFO_0000115"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;Cell"/>
					</owl:Restriction>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&bfo;BFO_0000115"/>
						<owl:allValuesFrom rdf:resource="&iof-construct;Cell"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<skos:example>CHO Cell Line;  FACS-isolated CD4+ T cell population; Red blood cell pellet; freshly isolated hepatocytes from mouse liver</skos:example>
		<iof-av:firstOrderLogicDefinition>CellPopulation(x) ↔ ObjectAggregate(x) ∧ ∃y(Cell(y) ∧ hasMemberPartAtSomeTime(x, y)) ∧ ∀z(hasMemberPartAtSomeTime(x, z) → Cell(z))</iof-av:firstOrderLogicDefinition>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">object aggregate which only has cells as its member parts</iof-av:naturalLanguageDefinition>
		<iof-av:semiFormalNaturalLanguageDefinition>every instance of &apos;cell population&apos; is defined as exactly an instance of &apos;object aggregate&apos; that &apos;has member part at some time&apos; some &apos;cell&apos; and &apos;has member part at some time&apos; only &apos;cell&apos;</iof-av:semiFormalNaturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;ClonedCellLine">
		<rdfs:subClassOf rdf:resource="&iof-construct;CellLine"/>
		<rdfs:label xml:lang="en-US">cloned cell line</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:example>CHO DG44 clone 5F7 – a clonal derivative of CHO DG44 cells selected for high monoclonal antibody productivity; Jurkat E6-1 – a cloned subline of Jurkat cells used in T cell signaling research</skos:example>
		<iof-av:adaptedFrom>https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cell-clone#:~:text=Clone%20of%20cells%20is%20a,ignored%20that%20may%20be%20different and CLO:0000177</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>1) A cloned cell line consists of cells that are genetically identical with respect to antigen recognition, gene sequence, and key phenotypic traits. It represents a uniform lineage of cells with shared ancestry and consistent functional characteristics.
2) Regulatory standards in biologics require proof of monoclonality for a production cell line. This implies that it originates from a single progenitor cell, regardless of whether one calls it a clone or a line. In practice, a clone is the starting point for development: once selected and scaled, it becomes a permanent cell line with specific attributes used for product manufacture.
3) FDA considers monoclonality essential: production cell lines must originate from a single progenitor cell to ensure consistent and safe product characteristics. Each clone selected after transfection or genetic manipulation is treated as a distinct cell line, subject to full characterization (identity, purity, adventitious agent testing, etc.)</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>ClonedCellLine(x) → CellLine(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">cell line that originates from a single ancestral cell</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are insufficient constructs to define necessary and sufficient conditions.</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;cloned cell line&apos; then x is a &apos;cell line&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;Concentration">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000019"/>
		<rdfs:label>concentration</rdfs:label>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CultureMedium">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:label xml:lang="en-US">culture medium</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:example>DMEM;LB agar;HEK293</skos:example>
		<iof-av:adaptedFrom>https://pmc.ncbi.nlm.nih.gov/articles/PMC7417654/pdf/fbioe-08-00911.pdf and https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/microbiological-testing/microbial-culture-media-preparation/types-of-media-in-microbiology?srsltid=AfmBOopAW7ApixpJ8J-96cmEfgfSiT8dX8wszs06BrclD3tYImJkEcYV</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>1) “Specific metabolic activity” refers to those metabolic processes that are intentionally supported or induced by the medium in a manufacturing or experimental context. This includes the synthesis and secretion of desired biomolecules (e.g., recombinant proteins, metabolites) or the replication and viability of cells when the cells themselves are the intended product. It excludes background or non-targeted metabolic processes such as basal energy maintenance or stress responses not relevant to the production goal.
2) In the context of biomanufacturing, “specific metabolic activity” typically refers to the set of biochemical processes carried out by microorganisms or cells that result in the synthesis, modification, and/or secretion of desired biological products. This includes processes such as the expression of recombinant proteins (e.g., monoclonal antibodies, enzymes), production of metabolites (e.g., amino acids, organic acids, antibiotics), or replication of the cells themselves when they are the product. These activities require the uptake and transformation of nutrients and are influenced by the composition and physicochemical properties of the culture medium.
4)Some types of culture media also include selection agents or antibiotics to suppress the growth of unwanted or contaminating organisms.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>CultureMedium(x) → MaterialEntity(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">material entity that is a liquid or solid aqueous formulation that provides essential nutrients (such as carbon, nitrogen, vitamins, and minerals) and controlled physicochemical conditions (such as pH and osmotic balance) required for the growth, maintenance, or specific metabolic activity of microorganisms or cells</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are insufficient constructs to accurately represent the structure and the capabilities that the media has in this release. They will be treated in great detail for a subsequent release orienting around upstream.</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;culture medium&apos; then x is a &apos;material entity&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CulturedCell">
		<rdfs:subClassOf rdf:resource="&iof-construct;Cell"/>
		<rdfs:label xml:lang="en-US">cultured cell</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:example>CHO-K1 cell;HeLa cell</skos:example>
		<iof-av:adaptedFrom>https://www.thermofisher.com/rs/en/home/references/gibco-cell-culture-basics/introduction-to-cell-culture.html and http://purl.obolibrary.org/obo/CL_0000010</iof-av:adaptedFrom>
		<iof-av:counterExample>Freshly isolated hepatocyte; Hematopoietic stem cell isolated from bone marrow</iof-av:counterExample>
		<iof-av:explanatoryNote xml:lang="en-US">1)Cultured cells are typically immortalized, meaning they retain the capacity to proliferate indefinitely under suitable growth conditions; in contrast, primary cells such as those directly isolated from a patient without genetic or oncogenic modification undergo a limited number of mitotic divisions before entering senescence or undergoing cell death
		2) A blurred line would be the case of the CAR-T cell therapy situation where the cells are often taken directly from the patient, modified (not immortalized), expanded in a bioreactor and then infused back into the patient. In this case, CAR-T cells are still considered cultured cells because they are subjected to ex vivo cultivation under controlled, artificial conditions. After being isolated from a patient (typically as primary T cells), they are genetically modified and then expanded in bioreactors or culture vessels using defined media, gas control, and temperature regulation. Although they are not immortalized, they undergo proliferation outside their native environment. This fulfills the defining criteria of a cultured cell as one that grows in an artificial, controlled setting. Their classification as cultured reflects the environmental and procedural context, not the permanence or origin of the cell line.</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>CulturedCell(x) → Cell(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">cell that is grown, maintained, or adapted to grow in a controlled artificial environment that supports its survival and proliferation</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are currently inssuficient constructs to adequately represent adapt to grow in artificial environment.</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;cultured cell&apos; then x is a &apos;cell&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;CulturedCellPopulation">
		<rdfs:subClassOf rdf:resource="&iof-construct;CellPopulation"/>
		<rdfs:label xml:lang="en-US">cultured cell population</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&iof-construct;CellPopulation">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&bfo;BFO_0000115"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;CulturedCell"/>
					</owl:Restriction>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&bfo;BFO_0000115"/>
						<owl:allValuesFrom rdf:resource="&iof-construct;CulturedCell"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<skos:example>population of CHO-K1 cell; population of HeLa cell;</skos:example>
		<iof-av:adaptedFrom>OBI:0100060</iof-av:adaptedFrom>
		<iof-av:firstOrderLogicDefinition>CulturedCellPopulation(x) ↔ CellPopulation(x) ∧ ∃y(CulturedCell(y) ∧ hasMemberPartAtSomeTime(x, y)) ∧ ∀z(hasMemberPartAtSomeTime(x, z) → CulturedCell(z))</iof-av:firstOrderLogicDefinition>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">cell population which only has cultured cells as its member parts</iof-av:naturalLanguageDefinition>
		<iof-av:semiFormalNaturalLanguageDefinition>every instance of &apos;cultured cell population&apos; is defined as exactly an instance of &apos;cell population&apos; that &apos;has member part at some time&apos; some &apos;cultured cell&apos; and &apos;has member part at some time&apos; only &apos;cultured cell&apos;</iof-av:semiFormalNaturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;GrowthMedium">
		<rdfs:subClassOf rdf:resource="&iof-construct;CultureMedium"/>
		<rdfs:label>growth medium</rdfs:label>
		<iof-av:naturalLanguageDefinition>culture medium that provides nutrients and suitable conditions to support the growth or maintenance of microorganisms or cells</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;HostCell">
		<rdfs:subClassOf rdf:resource="&iof-construct;Cell"/>
		<rdfs:label>host cell</rdfs:label>
		<skos:example>A HEK293 cell that has been infected by an adenovirus vector; MDCK cell infected by influenza virus; A CHO cell infected by vesicular stomatitis virus (VSV)</skos:example>
		<iof-av:adaptedFrom>http://purl.obolibrary.org/obo/NCIT_C93037</iof-av:adaptedFrom>
		<iof-av:counterExample>A HEK293T cell that has been transduced with a replication-deficient AAV vector to express a therapeutic gene</iof-av:counterExample>
		<iof-av:naturalLanguageDefinition>cell that is infected by a virus or another type of microorganism</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;IntermediateStockSolution">
		<rdfs:subClassOf rdf:resource="&iof-construct;Solution"/>
		<rdfs:label>intermediate stock solution</rdfs:label>
		<skos:example>A 0.1 M NaCl solution prepared from a 1 M stock and used to prepare a 1 mM NaCl solution for an assay</skos:example>
		<iof-av:adaptedFrom>http://champ-project.org/images/ontology/cao.owl#CAO_000142</iof-av:adaptedFrom>
		<iof-av:counterExample>A 50 mM Tris-HCl buffer prepared from a 1 M stock and used directly in an assay</iof-av:counterExample>
		<iof-av:naturalLanguageDefinition>solution prepared by diluting a stock solution and subsequently used to prepare additional dilutions</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MasterCellBank">
		<rdfs:subClassOf rdf:resource="&iof-construct;CellBank"/>
		<rdfs:label>master cell bank</rdfs:label>
		<iof-av:adaptedFrom>https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-5-d-derivation-and-characterisation-cell-substrates-used-production-biotechnologicalbiological-products-step-5_en.pdf</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>The master cell bank is the definitive, long-term preserved reference lot of a cell line. It serves as the primary source for the generation of working cell banks, but it may also be used directly as a production or study starting material when required. Preparation and characterization of the master cell bank must comply with ICH Q5D requirements, including full documentation of cell origin and banking procedures, and rigorous testing to confirm identity, purity (absence of microbial, viral, or other adventitious agents), and stability. Depending on the cell type and intended use, additional evaluations such as tumorigenicity or karyology are also required.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>cell bank produced in a single preparation event from a well-characterized cell line or clone, stored under validated cryogenic conditions, and established as the authoritative reference lot for direct use or the generation of further banks</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialDifferentiationInducer">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducer"/>
		<rdfs:label>material differentiation inducer</rdfs:label>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&iof-construct;MaterialFunctionalInducer">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&iof-core;hasRole"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;MaterialDifferentiationInducerRole"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<iof-av:naturalLanguageDefinition>material entity with a material differentiation inducer role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialDifferentiationInducerRole">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducerRole"/>
		<rdfs:label>material differentiation inducer role</rdfs:label>
		<skos:example>IL-7 and IL-15 solution bearing a differentiation inducer role when added to CAR-T cell cultures to promote memory T-cell phenotype; Activin A bearing a differentiation inducer role when added to human pluripotent stem cell cultures to direct differentiation toward definitive endoderm lineage</skos:example>
		<iof-av:adaptedFrom>https://pmc.ncbi.nlm.nih.gov/articles/PMC10215625/ and https://pmc.ncbi.nlm.nih.gov/articles/PMC9043864/</iof-av:adaptedFrom>
		<iof-av:counterExample>Glucose feed added to sustain T-cell metabolism</iof-av:counterExample>
		<iof-av:explanatoryNote>Differentiation inducers are commonly cytokines, growth factors, or small molecules that alter developmental programs in culture</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added, or planned to be added, to a cell culture to activate signaling pathways that drive cell fate decisions, lineage commitment, or functional specialization</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialFunctionalInducer">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:label>material functional inducer</rdfs:label>
		<iof-av:naturalLanguageDefinition>material entity with a material functional inducer role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialFunctionalInducerRole">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000023"/>
		<rdfs:label>material functional inducer role</rdfs:label>
		<iof-av:explanatoryNote>Functional inducers are distinct from standard nutrients or media supplements. They do not merely sustain viability or growth, but instead initiate or modulate a specific cellular function. In other words while media supplements support or maintain inherent cellular activities; they do not by themselves activate new pathways. In contrast, functional inducers are used to trigger or redirect specific pathways or functions (e.g., IPTG induction of the lac operon, tetracycline induction of recombinant protein expression).</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added, or planned to be added, to a cell culture, organism, or microbial community in order to trigger, enhance, or repress a specific cellular activity or pathway beyond baseline nutrient support</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialMetabolicInducer">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducer"/>
		<rdfs:label>material metabolic inducer</rdfs:label>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&iof-construct;MaterialFunctionalInducer">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&iof-core;hasRole"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;MaterialMetabolicInducerRole"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<iof-av:naturalLanguageDefinition>material entity with a material metabolic inducer role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialMetabolicInducerRole">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducerRole"/>
		<rdfs:label>material metabolic inducer role</rdfs:label>
		<skos:example>Lactose as a metabolic inducer in E. coli cell culture via lac operon activation.; Arabinose serving as a metabolic inducer in gut microbial communities.;Hydrocarbons acting as metabolic inducers in soil bacteria activating catabolic pathways.</skos:example>
		<iof-av:adaptedFrom>https://pmc.ncbi.nlm.nih.gov/articles/PMC3815394/</iof-av:adaptedFrom>
		<iof-av:counterExample>Sodium butyrate added to a HEK293 culture to boost viral vector yield</iof-av:counterExample>
		<iof-av:explanatoryNote>Metabolic inducers are most often substrates, substrate analogues, or related metabolites that relieve repression or otherwise activate transcription of genes for metabolic activity. They serve to adapt cellular metabolism to nutrient availability or environmental conditions, whether in controlled laboratory cultures, whole organisms, or natural microbial communities (e.g., soil, gut, biofilms).</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added, or planned to be added, to a cell culture, organism, or microbial community to activate expression of enzymes or pathways involved in the utilization or regulation of metabolites</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialProductionInducer">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducer"/>
		<rdfs:label>material production inducer</rdfs:label>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&iof-construct;MaterialFunctionalInducer">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&iof-core;hasRole"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;MaterialProductionInducerRole"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<iof-av:naturalLanguageDefinition>material entity with a material production inducer role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MaterialProductionInducerRole">
		<rdfs:subClassOf rdf:resource="&iof-construct;MaterialFunctionalInducerRole"/>
		<rdfs:label>material production inducer role</rdfs:label>
		<skos:example>Tetracycline bearing a production inducer role when added to a mammalian cell culture to activate a Tet-regulated promoter driving recombinant protein expression.</skos:example>
		<iof-av:adaptedFrom>https://pmc.ncbi.nlm.nih.gov/articles/PMC8015268/pdf/nihms-1685084.pdf and https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-024-02523-w</iof-av:adaptedFrom>
		<iof-av:counterExample>Glucose feed added to sustain metabolism and cell viability, which supports growth but does not trigger synthesis of a specific target product.</iof-av:counterExample>
		<iof-av:explanatoryNote>Production inducers are used in engineered culture systems to control when and how product formation occurs. They may be chemical compounds (e.g., tetracycline, arabinose, sodium butyrate) or environmental triggers (e.g., temperature shift, pH, light). The same compound may bear other roles in different contexts (for example, tetracycline as a therapeutic antibiotic). Environmental triggers such as temperature shifts, pH changes, oxygen limitation, or nutrient depletion can also induce product formation, but these are not material entities and do not bear a production inducer role.These will be modeled separately in a future version.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added, or planned to be added, to a cell culture to trigger the synthesis of a target product</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MediaSupplement">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:label>media supplement</rdfs:label>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&bfo;BFO_0000040">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&iof-core;hasRole"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;MediaSupplementRole"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<iof-av:naturalLanguageDefinition>material entity with a media supplement role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MediaSupplementRole">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000023"/>
		<rdfs:label>media supplement role</rdfs:label>
		<skos:example>Albumin stock solution bearing a media supplement role when added to serum-free medium to stabilize cells; ITS+3 Liquid Media Supplement (100×), a defined mixture of insulin, human transferrin, sodium selenite, linoleic acid, oleic acid ) added to serum-free medium to support viability and specialized functions; G418 (geneticin) added to impose selective pressure on a stable CHO line; 10% DMSO added to a cryopreservation medium for cell banking</skos:example>
		<iof-av:adaptedFrom>https://www.labome.com/method/Cell-Culture-Media-A-Review.html and https://www.thermofisher.com/rs/en/home/life-science/cell-culture/mammalian-cell-culture/media-supplements.html</iof-av:adaptedFrom>
		<iof-av:counterExample>Albumin used as a blocking agent in immunoassays; Dulbecco’s Modified Eagle Medium (DMEM), a complete culture medium formulation providing baseline nutrients, is a culture medium and not a media supplement; Sterile water used as a solvent to reconstitute culture medium powder</iof-av:counterExample>
		<iof-av:explanatoryNote>1) This role is context-dependent: a substance only counts as a media supplement when it is actually used or planned to be used to supplement culture media. The same chemical could serve other purposes in other settings (for example, insulin as a therapeutic drug). However, many commercial products (such as ITS mixes, lipid concentrates, or amino acid solutions) are specifically formulated and sold for use as media supplements. In practice, these preparations almost always bear a media supplement role.
2) Role may be held by single components and their solutions (such as insulin, transferrin, or glutamine) or prepared mixtures supplied as concentrated supplement solutions (e.g., ITS+3, MEM non-essential amino acids).
3) Media supplements are  distinct from the medium itself (basal/complete formulations are not “supplements”). A component that is part of a basal recipe does not bear this role but a component added on top of a basal medium does.
4) Media supplements are separate from nutrient replenishement feeds and the additions during cultivation specifically to replenish depleted nutrients should be modeled under nutrient replenishment role</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added or planned to be added to culture media to enrich or modify the medium composition or functional properties</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;MolarMass">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000019"/>
		<rdfs:label xml:lang="en-US">molar mass</rdfs:label>
		<rdfs:isDefinedBy rdf:resource="https://spec.industrialontologies.org/ontology/biopharma/Material/"/>
		<skos:altLabel>molecular weight</skos:altLabel>
		<skos:example>The molar mass of albumin is 66.5 kDa; The molar mass of a particular antibody mixture that contains a percentage of mAb dimers is 175 kDa while a population without dimers would have a molar mass of 150 kDa; The molar mass for a population of high density polyethylene polymer is 300 000 g/mol; molar mass of glucose is 180 g/mol; molar mass of sodium chloride is 58.44 g/mol</skos:example>
		<iof-av:adaptedFrom>https://spec.pistoiaalliance.org/idmp/ontology/ISO/ISO11238-Substances/MolecularWeight and PATO:0001681</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>1) The value of molecular weight is typically expressed in daltons (Da) or grams per mole (g/mol) 
2) In case of a heterogenous population of molecular entities it can be a regular average or a weighted awerage whereby the weigthing depends on the application
3) Molar mass includes small molecules, charged species, ionic compounds (treated as a defined unit), and macromolecular complexes such as proteins with tertiary or quaternary structure. It excludes isolated atoms and unspecified atomic groups (e.g. R-groups)</iof-av:explanatoryNote>
		<iof-av:firstOrderLogicAxiom>MolarMass(x) → Quality(x)</iof-av:firstOrderLogicAxiom>
		<iof-av:isPrimitive rdf:datatype="&xsd;boolean">true</iof-av:isPrimitive>
		<iof-av:naturalLanguageDefinition xml:lang="en-US">quality that is the quality of a molecular entity or population of molecular entities, and is either the mass of one mole of that single entity, or the average mass of one mole of molecules in the population</iof-av:naturalLanguageDefinition>
		<iof-av:primitiveRationale>There are insufficient constructs to define necessary and sufficient conditions.</iof-av:primitiveRationale>
		<iof-av:semiFormalNaturalLanguageAxiom>if x is a &apos;molar mass&apos; then x is a &apos;quality&apos;</iof-av:semiFormalNaturalLanguageAxiom>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;NutrientFeed">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:label>nutrient feed</rdfs:label>
		<owl:equivalentClass>
			<owl:Class>
				<owl:intersectionOf rdf:parseType="Collection">
					<rdf:Description rdf:about="&bfo;BFO_0000040">
					</rdf:Description>
					<owl:Restriction>
						<owl:onProperty rdf:resource="&iof-core;hasRole"/>
						<owl:someValuesFrom rdf:resource="&iof-construct;NutrientFeedRole"/>
					</owl:Restriction>
				</owl:intersectionOf>
			</owl:Class>
		</owl:equivalentClass>
		<iof-av:naturalLanguageDefinition>material entity with a nutrient feed role</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;NutrientFeedRole">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000023"/>
		<rdfs:label>nutrient feed role</rdfs:label>
		<skos:example>concentrated glucose feed pumped to maintain glucose above a target setpoint; galactose feed added to modulate glycosylation; feed solution containing glucose, amino acids, vitamins, trace metals, and lipids added during cultivation to support high cell density and balanced metabolism</skos:example>
		<iof-av:adaptedFrom>https://www.bioprocessintl.com/biochemicals-raw-materials/nutrient-supplementation-strategies-for-biopharmaceutical-production</iof-av:adaptedFrom>
		<iof-av:counterExample>IPTG induction; glucose already present in the medium</iof-av:counterExample>
		<iof-av:explanatoryNote>This role applies to additions that are part of a controlled feeding strategy after inoculation. The purpose of nutrient feeds can include sustaining cell growth and viability, preventing nutrient depletion, extending the productive phase, optimizing productivity, or steering metabolic activity to achieve desired product quality attributes (e.g., modulating glycosylation). Feeds are often chemically defined solutions and can be single or multicomponent solutioncontaining glucose, amino acids, vitamins, trace elements, and sometimes lipids, but may also be provided as powders or slurries in some settings.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>role held by a material entity when it is added or planned to be added to a cell cuture during cultivation or production to maintain or modulate nutrients</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;PH">
		<rdfs:subClassOf rdf:resource="&iof-construct;Concentration"/>
		<rdfs:label>pH</rdfs:label>
		<iof-av:naturalLanguageDefinition>molar concentration that is the amount of moles of hydrogen ions in a solution</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;ProductionMedium">
		<rdfs:subClassOf rdf:resource="&iof-construct;CultureMedium"/>
		<rdfs:label>production medium</rdfs:label>
		<iof-av:naturalLanguageDefinition>culture medium that provides nutrients and conditions to support product formation or other desired metabolic activities of microorganisms or cells during the production phase</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;Solution">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000040"/>
		<rdfs:label>solution</rdfs:label>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;StockSolution">
		<rdfs:subClassOf rdf:resource="&iof-construct;Solution"/>
		<rdfs:label>stock solution</rdfs:label>
		<iof-av:adaptedFrom>https://goldbook.iupac.org/terms/view/09050 and https://www.sciencedirect.com/topics/mathematics/stock-solution</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>1) A stock solution is usually of a greater concentration than is needed for the chemical purpose and is diluted to give the required concentration before use.
2) Because the solute concentration is accurately known, stock solutions allow reproducible preparation of dilutions or direct additions in planned processes. Their reliability depends on correct preparation and appropriate storage conditions, since degradation or evaporation can introduce concentration errors over time.
3) Dilutions of a stock solution result in creating of a working solution or an intermediate stock solution</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>solution with an accurately known solute concentration prepared so that smaller volumes can be used directly or diluted as needed for use in a planned process</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;VirusSeed">
		<rdfs:subClassOf rdf:resource="&bfo;BFO_0000027"/>
		<rdfs:label>virus seed</rdfs:label>
		<iof-av:naturalLanguageDefinition>object aggregate that has as parts aliquots of a virus preparation derived from a single, well-defined virus source, prepared and stored under controlled conditions, and maintained as a referenceable lot to provide consistent starting material for research, development, manufacturing, or the generation of new virus seeds</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;WorkingCellBank">
		<rdfs:subClassOf rdf:resource="&iof-construct;CellBank"/>
		<rdfs:label>working cell bank</rdfs:label>
		<iof-av:adaptedFrom>https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-5-d-derivation-and-characterisation-cell-substrates-used-production-biotechnologicalbiological-products-step-5_en.pdf</iof-av:adaptedFrom>
		<iof-av:explanatoryNote>The source cells are expanded into a homogeneous suspension from one or more vials of the master cell bank, dispensed into multiple uniform containers, and cryopreserved under validated long-term storage conditions. The resulting working cell bank serves as the routine production cell source, allowing repeated use while minimizing the need to access the master cell bank directly.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>cell bank that has as members cryopreserved cell aliquots prepared from one or more aliqots of a master cell bank and stored under validated cryogenic conditions for routine operational use in research development or manufacturing</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:Class rdf:about="&iof-construct;WorkingSolution">
		<rdfs:subClassOf rdf:resource="&iof-construct;Solution"/>
		<rdfs:label>working solution</rdfs:label>
		<skos:example>50 mM Tris-HCl prepared by diluting a 1 M Tris stock solution for use in an enzymatic assay</skos:example>
		<iof-av:adaptedFrom>https://www.fda.gov/regulatory-information/search-fda-guidance-documents/m10-bioanalytical-method-validation-and-study-sample-analysis and http://champ-project.org/images/ontology/cao.owl#CAO_000214</iof-av:adaptedFrom>
		<iof-av:counterExample>A 1 M Tris-HCl stock solution stored for later dilutions</iof-av:counterExample>
		<iof-av:explanatoryNote>Working solutions are derived from stock solutions and adjusted to the concentrations required for assays, buffer systems, culture additives, or other procedures. They are intended for immediate or short-term use and are usually less concentrated than the stock from which they are prepared.</iof-av:explanatoryNote>
		<iof-av:naturalLanguageDefinition>solution prepared by diluting a stock or intermediate stock solution to the concentration required for direct use in a planned process that is not itself a dilution process</iof-av:naturalLanguageDefinition>
	</owl:Class>
	
	<owl:AllDisjointClasses>
		<owl:members rdf:parseType="Collection">
			<rdf:Description rdf:about="&iof-construct;Cell">
			</rdf:Description>
			<rdf:Description rdf:about="&iof-construct;CellCulture">
			</rdf:Description>
			<rdf:Description rdf:about="&iof-construct;CultureMedium">
			</rdf:Description>
			<rdf:Description rdf:about="&iof-construct;CulturedCellPopulation">
			</rdf:Description>
		</owl:members>
	</owl:AllDisjointClasses>
</rdf:RDF>